Evonik Health Care, a part of global specialty chemicals company Evonik, opened a new applied technology laboratory in Bangkok, Thailand for the development of oral formulations for drugs and dietary supplements.
The new facility is the latest addition to Evonik’s global network of Health Care laboratories, and is the first laboratory in Southeast Asia for the Business Line Health Care.Dr. Stefan Randl, Vice President of Sales & Services at Evonik Health Care for Asia, said Southeast Asia is a significant growth region for Evonik Health Care.
“This new laboratory will allow us to work more closely with our customers on formulation solutions using our Eudragit and Eudraguard- functional polymer platforms. As local technical and regulatory requirements become more stringent, we felt it was timely to invest to strengthen our customer support in the region,” Randl added.
Eudragit polymers have outstanding protective, enteric and sustained-release properties. They are the pharmaceutical industry’s preferred solution for targeted drug release of solid oral dosage forms. Eudraguard is a broad toolkit of polymers which has been specifically developed for the nutraceutical
industry. It is used to coat dietary supplements for targeted delivery, improved uptake in the body, and better bioavailability.
The applied technology laboratory is equipped with a drum coater and fluidized bed for drying, granulation and coating. In addition, it has analytical capabilities, for example to conduct drug release tests. These resources enable Evonik to train customers and partners on the use of its polymer excipients, to develop oral formulations and to provide production support.
The new applied technology laboratory resides within Evonik’s expanded office facilities located in Bangkok’s Exchange Tower. “After being active in Thailand for more than 30 years, our newly expanded office premises in Bangkok will allow us to further grow and enhance our presence in the country,” remarked Peter Meinshausen, Regional President of Evonik South East Asia, Australia and New Zealand. “In light of this development, and the newly established Health Care laboratory, I am very much looking forward to continuing to build on our momentum in this dynamic and prosperous region.”